Diabetic Peripheral Neuropathy

Burden of Illness Associated with Painful Diabetic Peripheral Neuropathy Among Adults Seeking Treatment in the US

Pfizer, Inc. supported a study to characterize the burden of illness among adult patients with DPN receiving treatment in the US. They recruited 112 patients during routine visits at general practitioners and specialist sites who completed a one-time questionnaire that included symptom duration, out-of-pocket costs, validated pain measures, and other assessments. The full study and conclusions are …

Burden of Illness Associated with Painful Diabetic Peripheral Neuropathy Among Adults Seeking Treatment in the US Read More »

Poor Footwear Adherence Led to High Risk for Reulceration in Diabetes

Only 22-36% of diabetic peripheral neuropathy patients self-report that they wear prescription footwear regularly, especially at home, according to researchers in the Netherlands. According to their study, which monitored at home usage of prescription footwear, people do not wear their prescription shoes at home enough to prevent recurrent ulcers; it has been shown that ulcer …

Poor Footwear Adherence Led to High Risk for Reulceration in Diabetes Read More »

Gait Abnormalities Found in Diabetic Neuropathy

Dr. Alessandra Martinelli and her colleagues from the School of Science and Technology in Brazil, evaluated the spatial variables of gait and isometric muscle strength in patients with diabetic peripheral neuropathy. They found that the ankle, muscle strength, and ankle mobility variables could explain differences differences in gait speed and range of motion.  READ MORE …

Gait Abnormalities Found in Diabetic Neuropathy Read More »

Weight-bearing versus Non-weight-bearing Exercise for People with Diabetes and Peripheral Neuropathy

Results of a randomized controlled clinical trial are being published to report on the effects of weight-bearing versus non-weight-bearing exercise for people with diabetic peripheral neuropathy. Participants were recruited from a university-based physical therapy clinic. A relatively small study group had six-minute walk distance and daily step counts measured for 12 weeks, with the weight-bearing …

Weight-bearing versus Non-weight-bearing Exercise for People with Diabetes and Peripheral Neuropathy Read More »

cannabis for nerve pain

Drug Offers New Pain Management Therapy for Diabetics

A new drug therapy, nabilone, has been tested at University of Calgary’s Hotchkiss Brain Institute. At the end of the study, patients reported less pain and an improvement in sleep and anxiety when taking nabilone. The drug is currently used in Canada to treat nausea in chemotherapy patients. Nabilone is a synthetic cannabinoid, which mimics some …

Drug Offers New Pain Management Therapy for Diabetics Read More »

Recognizing and Treating Diabetic Peripheral Neuropathy

Dr. Charles E. Argoff, Albany (NY) Medical Center, discussed diabetic peripheral neuropathy at PAINWeek 2012. He provided instruction in how to recognize and treat DPN. Quality of life is heavily impacted by DPN and there is increased medication and burden on the healthcare system, with a cost of up to $13.7 billion dollars annually. Dr. …

Recognizing and Treating Diabetic Peripheral Neuropathy Read More »

Drugs Similar in Efficacy for Neuropathic Pain in Diabetes

Julia Boyle, PhD., University of Surrey (UK), and colleagues conducted a study of Type 1 and Type 2 diabetics with chronic painful DPN taking common medications to treat DPN: amitryptiline (Elavil), duloxetine (Cymbalta), and pregabalin (Lyrica). Their goal was to assess the impact of these medications on pain, sleep, daytime functioning, and quality of life.  …

Drugs Similar in Efficacy for Neuropathic Pain in Diabetes Read More »

FDA Approves NUCYNTA ER Extended Release Oral Tablets

Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA ER is the first and only opioid approved by the FDA for this purpose. “Pain from DPN can be difficult to manage, leaving some patients …

FDA Approves NUCYNTA ER Extended Release Oral Tablets Read More »

Diabetic Nerve Pain More Common Than Doctors Think

The American Chronic Pain Society joined with Pfizer to conduct a survey on the prevalence of symptoms of diabetic peripheral neuropathy in patients with diabetes. Their results show that nerve pain is reported in about twice as many patients as estimated by healthcare providers. Additionally, the survey found gaps in communication between doctors, nurses, and …

Diabetic Nerve Pain More Common Than Doctors Think Read More »

New Type of Stem Cell Preparation Could Bring Pain Relief to Diabetics

New study has been published showing the potential of stem cells providing relief to people suffering from painful diabetic peripheral neuropathy (DPN). Stem Cells Translational Medicine published the study on July 9th. Inflammation is considered a major culprit in DPN. While there are treatments for the diabetes and to helping to alleviate pain, Dr. Ruth …

New Type of Stem Cell Preparation Could Bring Pain Relief to Diabetics Read More »